Wanjia Group Holdings Ltd 2022 AR2
The report outlines Wanjia Group Holdings Limited's sustainability performance and initiatives for the fiscal year 2021/22. The company focused on its pharmaceutical wholesale and distribution and hemodialysis treatment businesses in the PRC. Key achievements include providing anti-corruption training to directors and staff, and implementing energy-saving measures such as upgrading office lighting to LED. The company also actively engaged in community investment, promoting kidney health awareness and supporting COVID-19 prevention.
Company: Wanjia Group Holdings Ltd
Sector: Health Care
Country: Hong Kong
Year: 2022
Type: AR2
Pages: 250
Wanjia Group Holdings Ltd
Annual Report
The report outlines Wanjia Group Holdings Limited's sustainability performance and initiatives for the fiscal year 2021/22. The company focused on its pharmaceutical wholesale and distribution and hemodialysis treatment businesses in the PRC. Key achievements include providing anti-corruption training to directors and staff, and implementing energy-saving measures such as upgrading office lighting to LED. The company also actively engaged in community investment, promoting kidney health awareness and supporting COVID-19 prevention.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English, Chinese
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees